metformin has been researched along with Digestive System Neoplasms in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hue-Fontaine, L | 1 |
| Lemelin, A | 1 |
| Forestier, J | 1 |
| Raverot, G | 1 |
| Milot, L | 1 |
| Robinson, P | 1 |
| Borson-Chazot, F | 1 |
| Lombard-Bohas, C | 1 |
| Walter, T | 1 |
1 other study available for metformin and Digestive System Neoplasms
| Article | Year |
|---|---|
Metformin and everolimus in neuroendocrine tumours: A synergic effect?
Topics: Aged; Antineoplastic Agents; Cohort Studies; Diabetes Mellitus; Digestive System Neoplasms; Drug Syn | 2020 |